The goal of this clinical trial is to determine effect of arginine and glutamine onoutcome of COVID-19 patients. The main questions it aims to answer are:-to test the effect of oral nutritional supplements containing arginine and glutamine oncovid-19 patients outcome Dr. M. Djamil General Hospital PadangParticipants will given ONS containing arginine and glutamine. Researchers will compareintervention group with control group to see if ONS affected outcome of COVID-19 patients
Not Provided
Dietary Supplement: Neomune
Neomune containing 4.8 g arginine and 2 g glutamine
Inclusion Criteria:
- Patients confirmed positive for COVID-19
- Age over 17 years
- The patient can take food orally
Exclusion Criteria:
- Patients with restricted fluid intake
- Patients who cannot take food orally
- suffering from diabetes mellitus and kidney failure
Dr. M. Djamil General Hospital
Padang 1633419, West Sumatera, Indonesia
Not Provided